Germany Seeks PTC Therapeutics (PTCT) Translarna Discount - Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Marvell shares jump after giving Google warrants amid custom chip deal
Wedbush Downgrades PTC Therapeutics (PTCT) to Neutral
March 1, 2016 7:29 AM ESTWedbush downgraded PTC Therapeutics (NASDAQ: PTCT) from Outperform to Neutral with a price target of $11.00 (from $27.00), saying lower Translarna estimates shift risk/reward.
Analyst Heather Behanna commented, "Though we still believe Translarna has a good chance of full EU approval, we are... More
Cowen Downgrades PTC Therapeutics (PTCT) to Market Perform
March 1, 2016 7:27 AM ESTCowen downgraded PTC Therapeutics (NASDAQ: PTCT) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on PTC Therapeutics click here. For more ratings news on PTC Therapeutics click here.
Shares of PTC Therapeutics closed at $7.98 yesterday.
... MoreBofA/Merrill Lynch Downgrades PTC Therapeutics (PTCT) to Neutral
February 29, 2016 8:58 AM ESTBofA/Merrill Lynch downgraded PTC Therapeutics (NASDAQ: PTCT) from Buy to Neutral.
For an analyst ratings summary and ratings history on PTC Therapeutics click here. For more ratings news on PTC Therapeutics click here.
Shares of PTC Therapeutics closed at $7.99 yesterday.
... MorePTC Therapeutics (PTCT) Offers Update on German Pricing and Reimbursement Process for Translarna
February 26, 2016 4:02 PM ESTPTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company has had multiple discussions with the German Federal Association of the Statutory Health Insurances (GKV-SV) over the last several months to come to agreement on pricing and reimbursement. Recently, these discussions transitioned into an arbitration process, which did... More
PTC Therapeutics (PTCT) Shares Decline; German Reimbursement Arbitration Panel Said to Cut Price of Ataluren by 65%
February 26, 2016 3:37 PM ESTPTC Therapeutics (NASDAQ: PTCT) declined Friday after theStreet's Feuerstein said the German reimbursement arbitration panel cuts the price of its DMD drug ataluren by 65%.
BREAKING $PTCT: German reimbursement arbitration panel cuts price of DMD drug ataluren by 65%. (Decision Feb. 25) pic.twitter.com/dPyMdza7U5
Adam Feuerstein (@adamfeuerstein) February 26, 2016... More
